KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Income towards Parent Company (2016 - 2025)

Evolent Health (EVH) has 11 years of Income towards Parent Company data on record, last reported at -$429.2 million in Q4 2025.

  • For Q4 2025, Income towards Parent Company fell 1780.59% year-over-year to -$429.2 million; the TTM value through Dec 2025 reached -$534.5 million, down 767.13%, while the annual FY2025 figure was -$534.5 million, N/A changed from the prior year.
  • Income towards Parent Company reached -$429.2 million in Q4 2025 per EVH's latest filing, down from -$20.9 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $3.1 million in Q4 2021 and bottomed at -$429.2 million in Q4 2025.
  • Average Income towards Parent Company over 5 years is -$41.7 million, with a median of -$18.6 million recorded in 2024.
  • Peak YoY movement for Income towards Parent Company: skyrocketed 196.43% in 2021, then tumbled 1780.59% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at $3.1 million in 2021, then tumbled by 471.54% to -$11.3 million in 2022, then tumbled by 122.82% to -$25.3 million in 2023, then grew by 9.7% to -$22.8 million in 2024, then crashed by 1780.59% to -$429.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Income towards Parent Company were -$429.2 million in Q4 2025, -$20.9 million in Q3 2025, and -$19.9 million in Q2 2025.